HTL Biotechnology and Echelon Biosciences Inc. announce strategic partnership to advance biopolymer platform and hyaluronic acid research tools
14.4.2021 13:00:00 EEST | Business Wire | Press release
HTL, the worldwide leader in biotechnology solutions using hyaluronic acid (HA) and other biopolymers, and Echelon Biosciences Inc., a U.S.-based global supplier of biochemical reagents, assays, and services to research and development laboratories, announced today their new distribution and product development partnership. The partnership will enable distribution of high-quality HA and glycosaminoglycan (GAG), and the co-development of novel GAG products.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210414005119/en/
HTL's campus is located in Paris, France. HTL, the worldwide leader in biotechnology solutions using hyaluronic acid (HA) and other biopolymers, and Echelon Biosciences Inc., a U.S.-based global supplier of biochemical reagents, assays, and services to research and development laboratories, announced today their new distribution and product development partnership. The partnership will enable distribution of high-quality HA and glycosaminoglycan (GAG), and the co-development of novel GAG products. https://htlbiotech.com/
The partnership provides academic research and pharmaceutical development laboratories’ expanded access to Good Manufacturing Practices (GMP)-grade, kit-packaged hyaluronic acid and glycosaminoglycan (GAG) products. By offering premium, clinical grade products to early-stage research investigators, the partnership seeks to bridge the gap between lab-based research, development and commercialization, and accelerate innovation worldwide.
“Innovation is at the heart of HTL’s DNA,” said HTL CEO Yvon Bastard. “This growth opportunity reinforces our mission and vision to apply science for increased bio-compatibility and improved health outcomes around the world.”
“This new partnership offers scientists and researchers the key technologies to develop innovative biopolymer solutions for new medical applications in aesthetics, ophthalmology, rheumatology, tissue engineering and drug delivery,” said Charles Ruban, HTL deputy CEO. “This is the true meaning of HTL’s tagline of ‘Beyond, together.’ HTL’s ambition is not only to grow its lead position in producing and distributing hyaluronic acid worldwide, but also to build tomorrow’s glycosaminoglycan-based solutions.”
“Echelon has been granted the opportunity to expand its market-leading HA assays and extra cellular matrix product line with the supply of HTL’s hyaluronic acid and other GAG-derived products. HTL is recognized internationally for producing biopolymers of premium quality,” says Bert Israelsen, president of Echelon Biosciences. “Echelon offers our customers access to the latest innovative tools with unparalleled technical support, thereby fully enabling maximized creativity in basic and applied research. With its fermentation and organic synthesis platforms, HTL creates functionality and added value by developing chemically modified biopolymers tailored to specific needs.”
“This new partnership is a milestone in HTL’s expanding footprint in the North American market and with the U.S. medical community,” said Glenn Prestwich, Ph.D., one of Echelon’s founders and now HTL’s exclusive science and innovation advisor for this market. By entrusting Echelon with the distribution of HTL’s hyaluronic acid and glycosaminoglycan products for research use, HTL aims to significantly increase its support and involvement in biopolymer research in the U.S. and worldwide, but also its research and development capacity.
“This new initiative demonstrates HTL’s commitment to invest in innovation in healthcare,” said Humberto C. Antunes, strategic advisor to HTL and former CEO of Galderma. “In the fields of health and wellness, the biotechnology ecosystem of innovation, incubators, and established and emerging companies are incredibly dynamic in the United States, Mexico and Canada. It means a huge growth potential for HTL products,” added Antunes.
About HTL
HTL is a biotechnology company, leading the way in the design and production of pharmaceutical grade hyaluronic acid and other innovative functional biopolymers for premium medical products. HTL serves the pharmaceutical and medical device industries worldwide, enabling them to transform lives of patients. HTL’s unsurpassed commitment to client partnership has been consistently proven in the marketplace. The company is recognized for supplying the highest quality products and continually investing in driving and supporting market growth. For over 25 years, its cutting-edge research and development has allowed to develop unique value-driven solutions to meet the innovation needs of its clients.
About Echelon Biosciences, Inc.
Based in Salt Lake City, Utah, Echelon Biosciences, was established in 1997 to supply synthetic lipid reagents for research and development. Since then, Echelon has successfully grown in scale and scope to include custom chemistry, peptides, and biological assays with over 700 catalog items in the fields of cell signaling, extracellular matrix, cancer drug discovery, and disease biomarkers.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210414005119/en/
Contact information
HTL
Dianne Danowski Smith, APR – Publix Northwest PR + PA
+1.503.201.7019 - dianne@publixnw.com
Echelon Biosciences, Inc.
Mark Nelson, PhD - Vice President Business and Science Development
+1 801-588-0455 - mnelson@echelon-inc.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Reply and the University of Milan Launch Experimental Research on Biological Computing Based on Cortical Labs’ CL1 Platform28.1.2026 16:10:00 EET | Press release
Reply [EXM, STAR: REY] today announced the start of a collaboration with the Department of Pathophysiology and Transplantation of the University of Milan, together with the “Centro Dino Ferrari” of the University of Milan - Ospedale Policlinico, for a new research and experimental initiative in the field of biological computing. The project aims to explore innovative approaches to learning and information processing through the integration of biological systems and digital technologies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260128715625/en/ This initiative represents the starting point of an advanced research programme aimed at exploring new computational paradigms. At the core of the initiative is the CL1 biological computer developed by Cortical Labs, an Australian biotechnology company. Unlike conventional silicon-based computing architectures, this technology leverages the processing capabilities of living human
Geoprofessionals Spend a Quarter of Their Time Managing Data and Are Increasingly Turning to AI, Reveals New Seequent Survey28.1.2026 16:00:00 EET | Press release
Seequent, the Bentley Subsurface company, says mining and civil geoprofessionals turning to AI still struggle to unlock value from increasingly complex, multisource datasets, according to its 7th Geoprofessionals Data Management Report. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260128879634/en/ Geoprofessionals spend a quarter of their time managing data and are increasingly turning to AI, reveals new Seequent survey. The global report, based on a survey of more than 1,000 geoprofessionals worldwide, highlights teams grappling with complex datasets across multiple software platforms, unmanaged historical data, and significant time spent on routine data administration. Angela Harvey, Chief Customer Officer, Seequent, said: ‘According to the report findings, geoprofessionals on average spend over a quarter of their time on data management. They are actively seeking to harness the information it contains for competitive ad
Brown Brothers Harriman Investor Services and SimCorp Forge Strategic Alliance to Provide Integrated End-to-End Technology, Data, and Services Solution for Global Asset Managers28.1.2026 16:00:00 EET | Press release
Brown Brothers Harriman (BBH), a privately held global financial services firm, and SimCorp, a leading global financial technology company, today announced a new strategic alliance to address the needs of global asset managers requiring an integrated, end-to-end technology, data, and services solution. Enhancing both firms’ existing offerings, this solution uses BBH Infomediary to integrate SimCorp One’s front and middle office capabilities, including a real-time IBOR managed by SimCorp’s Managed Business Services, with BBH’s fund servicing and custody suite. BBH Infomediary, BBH’s connectivity and data integration engine, will also enable a unique open architecture model that helps connect clients to third party technologies and service providers. “For managers seeking to streamline their technology and operations across the entire investment lifecycle, this offering delivers scalability, accelerates data strategies, and allows a sharper focus on investment results,” said Shawn McNinc
Wunderkind Joins Klaviyo Marketplace, Bringing Identity-Based Personalization and Revenue Growth to E-Commerce Brands28.1.2026 16:00:00 EET | Press release
Wunderkind, the AI decisioning platform that delivers identity resolution and cross-channel personalization to scale performance and reach, today announced its official debut on the Klaviyo App Marketplace. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260128210560/en/ The integration brings Wunderkind’s identity insights directly into Klaviyo’s B2C CRM, powering real-time profiles, segments, and flows that help brands recognize more customers earlier in the journey and deliver relevant experiences across email, SMS and other Klaviyo-powered channels. By layering Wunderkind’s industry-leading Identity Network — built on more than 9 billion device profiles and over a billion unique user identities — into Klaviyo’s unified customer profile, marketers can strengthen their understanding of who customers are, unify identity across channels, and activate personalization through Klaviyo without adding complexity to their tech stac
WeFi Technology Group Announces Partnership with PGA Tour Rising Star28.1.2026 15:40:00 EET | Press release
WeFi Technology Group, a global provider of technology-enabled working capital solutions, today announced a multi-year brand partnership with Aldrich Potgieter, the 2025 PGA Tour Rookie of the Year and one of the most promising young players on the international golf circuit. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260128340648/en/ Aldrich Potgieter, 2025 PGA Tour Rookie of the Year and one of the most promising young players on the international golf circuit. Leveraging its AI-powered platform, WeFi Technology operates at the intersection of finance, technology, and innovation in over 40 countries around the globe, delivering working capital solutions that drive client growth. Potgieter rose to global prominence at just 19 years old when he became the youngest winner in Korn Ferry Tour history, a milestone that signalled both elite talent and competitive maturity. His rapid progression since then, claiming his first
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom